MASSIRONI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 3.986
AS - Asia 3.369
EU - Europa 2.052
SA - Sud America 432
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 84
OC - Oceania 5
Totale 10.109
Nazione #
US - Stati Uniti d'America 3.784
SG - Singapore 1.030
VN - Vietnam 815
IT - Italia 696
CN - Cina 549
HK - Hong Kong 456
RU - Federazione Russa 360
BR - Brasile 319
DE - Germania 240
IE - Irlanda 182
SE - Svezia 170
CA - Canada 143
BD - Bangladesh 102
FR - Francia 91
GB - Regno Unito 77
IN - India 77
KR - Corea 59
ID - Indonesia 52
AR - Argentina 40
FI - Finlandia 37
MX - Messico 34
NL - Olanda 32
SA - Arabia Saudita 29
PL - Polonia 28
UA - Ucraina 28
ES - Italia 27
ZA - Sudafrica 27
IQ - Iraq 25
JP - Giappone 25
TR - Turchia 24
PH - Filippine 23
AT - Austria 22
CH - Svizzera 21
PK - Pakistan 21
EC - Ecuador 15
VE - Venezuela 15
KE - Kenya 14
PE - Perù 14
CO - Colombia 13
MY - Malesia 11
MA - Marocco 10
UZ - Uzbekistan 10
BE - Belgio 9
EG - Egitto 9
JM - Giamaica 8
JO - Giordania 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
TH - Thailandia 6
TW - Taiwan 6
MM - Myanmar 5
TT - Trinidad e Tobago 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
IL - Israele 4
LT - Lituania 4
SN - Senegal 4
BG - Bulgaria 3
HN - Honduras 3
LB - Libano 3
LY - Libia 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
AM - Armenia 2
AO - Angola 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
RO - Romania 2
SI - Slovenia 2
SR - Suriname 2
TJ - Tagikistan 2
BJ - Benin 1
BO - Bolivia 1
GD - Grenada 1
IR - Iran 1
KH - Cambogia 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MQ - Martinica 1
MT - Malta 1
NC - Nuova Caledonia 1
OM - Oman 1
QA - Qatar 1
SV - El Salvador 1
Totale 9.926
Città #
Singapore 715
Ann Arbor 510
Hong Kong 446
Ashburn 441
San Jose 375
Ho Chi Minh City 257
Milan 207
Hanoi 185
Dublin 177
Frankfurt am Main 155
Los Angeles 139
Chandler 118
Hefei 117
New York 114
Council Bluffs 113
Chicago 99
Toronto 97
Dallas 90
Santa Clara 89
Beijing 79
Fairfield 67
Wilmington 67
Rome 62
The Dalles 60
Shanghai 55
Buffalo 53
Seoul 50
Houston 49
Moscow 42
Princeton 41
Boardman 39
Lauterbourg 38
Haiphong 36
Columbus 35
Jakarta 34
Da Nang 32
São Paulo 32
Woodbridge 32
London 29
Seattle 27
Helsinki 25
Orem 25
Denver 24
Florence 23
Munich 23
Cambridge 22
Warsaw 21
Lawrence 20
Montreal 20
Ha Long 19
Tokyo 19
Brooklyn 18
Phoenix 18
San Diego 18
Altamura 17
Guangzhou 17
Nuremberg 17
Rio de Janeiro 17
Zurich 17
Bari 16
Biên Hòa 16
Hải Dương 16
Naples 16
Ninh Bình 16
Chennai 15
Bắc Ninh 14
Dhaka 14
Hangzhou 14
Atlanta 13
Thái Nguyên 13
Lima 12
Stockholm 12
Brasília 11
Mexico City 11
Salt Lake City 11
San Francisco 11
Boston 10
Guayaquil 10
Johannesburg 10
Miami 10
Nairobi 10
Tashkent 10
Vũng Tàu 10
Bologna 9
Bình Dương 9
Bắc Giang 9
Davao City 9
Mumbai 9
Newark 9
Belo Horizonte 8
Can Tho 8
Jeddah 8
Philadelphia 8
Phủ Lý 8
Quận Một 8
Roccalumera 8
Vienna 8
Amman 7
Cairo 7
Desio 7
Totale 6.223
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 741
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 353
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 331
Understanding short bowel syndrome: Current status and future perspectives 329
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 322
High rates of 30-day mortality in patients with cirrhosis and COVID-19 315
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 309
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 307
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 306
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 303
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 293
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 287
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 285
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 285
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 250
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 247
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 245
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 241
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 240
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 238
Eosinophilic esophagitis: does age matter? 232
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 229
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 216
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 215
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 202
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 200
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 198
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 191
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 188
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 185
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 179
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 179
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 159
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 158
Systematic review-Pancreatic involvement in inflammatory bowel disease 147
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 147
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 145
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 143
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 142
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 130
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 124
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 119
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study 54
Totale 10.109
Categoria #
all - tutte 34.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 0 0 55 28 41 28 3 22 28 24 22 79
2022/2023594 65 148 54 57 59 63 19 34 42 12 19 22
2023/2024673 18 11 17 85 62 151 120 33 58 17 13 88
2024/20251.891 90 164 157 77 148 99 137 57 152 334 207 269
2025/20265.130 979 397 318 556 549 246 684 187 333 333 247 301
2026/2027707 168 313 226 0 0 0 0 0 0 0 0 0
Totale 10.109